Editing A-Series (section)

== B-Series stabilization project ==

Rambam began the B-Series stabilization project in 2023 from archived low-passage A-Series master stock. Fresh Alexandru-derived material could act as a genetic reference, but it was not the project's main starting culture. Earlier endothelial commitment allowed more primitive vessels to form before the fastest organ growth. A perfusion-sensitive safeguard could slow local tissue development when blood supply fell behind.

The project produced a small number of physically mature prototypes. Their organs were better vascularized than those of unstable late A-Series clones, but some capillaries remained too permeable or mechanically weak. The resulting defects included edema and occasional microhemorrhage. Rambam did not approve industrial production before Snubable collapsed.

Later work coordinated pericyte recruitment with formation of the vascular basement membrane. Cellular signalling remained responsible for the main maturation process. The experimental incubator provided closed-loop support only when molecular evidence and functional measurements agreed that a vascular territory was falling behind.

The controller mapped temporary zones around the arterial branches supplying the affected tissue. Doppler ultrasound measured vessel position and blood-flow behavior. Photoacoustic imaging added hemoglobin distribution and tissue oxygenation. Regional correction combined maturation support with small flow changes, avoiding pressure that could damage immature capillaries.

Support was tapered after molecular development and vascular function returned to the expected ranges. The territory then had to remain stable for 30 minutes. Any renewed abnormality reset the timer and restored regional correction. Exact instrument resolution and intervention limits remained unresolved when the project ended.